Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report. Before that can happen though, the U.S. government needs to grant the company approval, which is far from certain. In 2022, the U.S. Food and Drug Administration rejected its application to proceed with human trials due to safety concerns. Neuralink has been working to address those concerns ever since.
Awakened by howling winds that tore through his Maui neighborhood, Shane Treu went out at dawn and saw a wooden power pole suddenly snap with a flash, its sparking, popping line falling to the dry grass below and quickly igniting a row of flames.
The wildfire that swept across Maui a week ago turned one of the nation’s most celebrated island vistas into an ashen moonscape and killed at least 99 people, a number that officials warn could rise by scores as the search continues.
